Medical Condition News

RSS

AFMC supports research to determine link between blood vessel anomalies and multiple sclerosis

The Association of Faculties of Medicine of Canada (AFMC), along with other organizations in Canada including the Multiple Sclerosis Society of Canada and the Canadian Institutes for Health Research, is in strong support of rigorous scientific research to determine the possible link between blood vessel anomalies and multiple sclerosis and the potential benefits of surgical intervention to relieve its symptoms.

23 Sep 2010

Over one in three diabetics do not take insulin as prescribed

More than one in three diabetes patients skip doses or fail to take their insulin as prescribed, stating that they have done so on average three times in the last month, and 77 percent of physicians estimate that in reality this number could be as high as six doses, according to the Global Attitudes of Patients and Physicians in Insulin Therapy (GAPP™) survey, released today by Novo Nordisk.

23 Sep 2010

Athersys presents MultiStem phase I study results at TCT Conference

Athersys, Inc. announced at its presentation at the Transvascular Cardiovascular Therapeutics (TCT) Conference held in Washington, D.C., updated results from its phase I clinical trial of MultiStem, its allogeneic cell therapy product, administered to individuals following acute myocardial infarction (AMI).

23 Sep 2010

Abbott announces positive results of bioresorbable vascular device at TCT conference

Abbott today announced positive nine-month results from the first 45 patients enrolled in the second stage of the ABSORB trial. At nine months, Abbott's bioresorbable vascular scaffold (BVS) demonstrated strong results that remained consistent with the six-month data from the same 45-patient group, with the rate of major adverse cardiac events (MACE) unchanged at 4.4 percent and no reports of blood clots (thromboses).

23 Sep 2010

Gersak develops Convergent Procedure for atrial fibrillation

During the recent Atrial Fibrillation Session of the Techno College at the European Association of Cardiac Thoracic Surgeons in Geneva, Switzerland, Professor Borut Gersak, Head of Cardiac Surgery from University Medical Center in Ljubljana, Slovenia challenged his audience of more than 1,000 medical professionals to think differently about existing atrial fibrillation surgical approaches.

23 Sep 2010

New iPhone application for breast cancer patients

Nonprofit Breastcancer.org has launched an iPhone application for breast cancer patients. The Breast Cancer Diagnosis Guide is a free mobile app that walks users through the breast cancer pathology report a vital report that sets the patient's treatment path.

23 Sep 2010

Erasmus Medical Center Professor to present LEADERS trial result at TCT symposium

Three-year data from the prospective, randomized LEADERS trial demonstrate the equivalence of a biolimus A9-eluting stent with a biodegradable polymer vs. a sirolimus-eluting stent with a durable polymer. The results will be presented at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

23 Sep 2010

Study finds adverse cardiac events rare during year after negative cardiac CTA scan

Adverse cardiac events are rare one year after patients are admitted to the emergency room with low-to-moderate risk chest pain and are discharged due to a negative cardiac computed tomography angiogram (CTA), according to a study in the October issue of the American Journal of Roentgenology. Cardiac CTA is a noninvasive heart-imaging test that determines whether fatty deposits or calcium deposits have built up in the coronary arteries that supply blood to the heart muscle.

23 Sep 2010

St. Jude Medical to highlight OCT product platform at TCT meeting

St. Jude Medical, Inc., a global medical device company, will highlight recently launched technology, including its new Optical Coherence Tomography (OCT) product platform, at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, D.C.

23 Sep 2010

Scientists to develop methotrexate nose drops for brain cancer

Scientists are reporting the development and successful initial testing of a new form of methotrexate the mainstay anticancer drug designed to be given as nose drops rather than injected. It shows promise as a more effective treatment for brain cancer, they say. The report appears in ACS' Molecular Pharmaceutics, a bi-monthly journal.

23 Sep 2010

Women who smoke during pregnancy can harm child's motor ability: Study

Women who smoke during pregnancy run the risk of adversely affecting their children's coordination and physical control according to a new study from rebro University, Sweden, published in the Journal of Epidemiology and Community Health.

23 Sep 2010

Interleukin Genetics announces clinical study data on osteoarthritis progression

Interleukin Genetics, Inc. and the Thurston Arthritis Research Center at the University of North Carolina at Chapel Hill announced today findings from a large clinical study to evaluate the role of genetic factors in osteoarthritis progression which showed patients with radiographic evidence of knee osteoarthritis who inherited a specific pattern of genetic variations in the interleukin-1 receptor antagonist (IL-1Ra) gene were almost twice as likely to progress to severe disease as other patients.

23 Sep 2010

Gore commences treatment in Europe with new 25 cm VIABAHN Endoprosthesis

W. L. Gore & Associates announced the treatment of the first European patients with the new 25 cm GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface, the longest length stent-graft available in Europe. Piotr Kasprzak, from the Department of Vascular Surgery at the Klinikum der Universität in Regensburg, Germany, and Thomas Zeller, MD, from the Department of Angiology at the Herz-Zentrum in Bad Krozingen, Germany successfully treated patients using the Gore device.

23 Sep 2010

New study signals hope for treatment of rare neurodegenerative disease

A new study led by St. Jude Children's Research Hospital scientists signals hope for treatment of a neurodegenerative disease and a new model for understanding the mechanism at work in other more common neurodegenerative disorders.

23 Sep 2010

Novartis applauds declaration of CML Awareness Day in Canada

Today is a meaningful milestone for chronic myelogenous leukemia (CML) patients and their families.

23 Sep 2010

UB researchers to investigate influence of environmental factors on MS progression

A $634,000 grant from the Department of Defense is allowing researchers at the University at Buffalo to investigate a trio of environmental factors and their influence on the progression of multiple sclerosis.

23 Sep 2010

Phase II study: Fostamatinib improves outcomes in RA patients

AstraZeneca's new oral syk inhibitor, fostamatinib (R788), recently in-licensed from Rigel Pharmaceuticals, Inc., significantly improved outcomes of patients with rheumatoid arthritis who responded inadequately to ongoing treatment with methotrexate, according to phase II study data published in The New England Journal of Medicine today.

23 Sep 2010

NCI selects Caliper's Quantum FX microCT system to study tumor models in lung cancer

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today announced that the National Cancer Institute has purchased Caliper's Quantum FX, a stand-alone microCT system for pre-clinical imaging, to study spontaneous tumor models in lung cancer.

23 Sep 2010

Implantation of new bioprosthetic-tissue valve in patients with severe aortic stenosis saves lives

Implantation of a new bioprosthetic-tissue valve into the hearts of patients who have severe aortic stenosis and are too sick or too old for open-heart surgery has been found to both save lives and improve the quality of those lives, according to a new multicenter study, to be published online at 2 p.m. Pacific time today in the New England Journal of Medicine.

23 Sep 2010

Chromium picolinate may cure inflammation associated with diabetic nephropathy: Research

Taking chromium picolinate may help lessen inflammation associated with diabetic nephropathy (kidney disease), say researchers at the Medical College of Georgia in Augusta.

23 Sep 2010

Medical Condition News

AFMC supports research to determine link between blood vessel anomalies and multiple sclerosis

Over one in three diabetics do not take insulin as prescribed

Athersys presents MultiStem phase I study results at TCT Conference

Abbott announces positive results of bioresorbable vascular device at TCT conference

Gersak develops Convergent Procedure for atrial fibrillation

New iPhone application for breast cancer patients

Erasmus Medical Center Professor to present LEADERS trial result at TCT symposium

Study finds adverse cardiac events rare during year after negative cardiac CTA scan

St. Jude Medical to highlight OCT product platform at TCT meeting

Scientists to develop methotrexate nose drops for brain cancer

Women who smoke during pregnancy can harm child's motor ability: Study

Interleukin Genetics announces clinical study data on osteoarthritis progression

Gore commences treatment in Europe with new 25 cm VIABAHN Endoprosthesis

New study signals hope for treatment of rare neurodegenerative disease

Novartis applauds declaration of CML Awareness Day in Canada

UB researchers to investigate influence of environmental factors on MS progression

Phase II study: Fostamatinib improves outcomes in RA patients

NCI selects Caliper's Quantum FX microCT system to study tumor models in lung cancer

Implantation of new bioprosthetic-tissue valve in patients with severe aortic stenosis saves lives

Chromium picolinate may cure inflammation associated with diabetic nephropathy: Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News